Rise Therapeutics Reports Ulcerative Colitis Dose Escalation Clinical Results for R-3750 at the Digestive Disease Week (DDW) Conference in San Diego May 3-6
Hand-out
Press Releases
Rise Therapeutics  
April 7, 2025

Rise Therapeutics Reports Ulcerative Colitis Dose Escalation Clinical Results for R-3750 at the Digestive Disease Week (DDW) Conference in San Diego May 3-6

Results highlight safety and promising clinical responses of R-3750, along with biomarker results demonstrating a differentiated immune mechanism

avatar profile Olean Times Herald

Olean Times Herald


Local & Social